On heels of drug pricing hearings, Democratic lawmakers kick off insulin probe

글 내용 전체보기

Samsung BioLogics sees sales rise but profit fall as it continues expansion

글 내용 전체보기

Senate bill backed by patient groups proposes value-based ‘annuity’ payments for pricey treatments

글 내용 전체보기

Johnson & Johnson’s Erleada trial stops early on good news, setting up case for new prostate cancer nod

글 내용 전체보기

What’s BMS saying about its Celgene buy behind the scenes? This transcript tells all

글 내용 전체보기

Aduro cuts 37% of employees as it refocuses on cancer pipeline

글 내용 전체보기

Sylentis’ dry eye drug misses primary goals in phase 3

글 내용 전체보기

EuroBiotech: More Articles of Note

글 내용 전체보기

EuroBiotech Report—Roche flop, EMA-Brexit, antibiotic R&D, Merck KGaA and Sylentis

글 내용 전체보기

Alexion bags option on Caelum to boost hematology franchise

글 내용 전체보기

First phase 3 data back Scynexis’ new-class antifungal

글 내용 전체보기

Calico brings on Amgen’s translational R&D head to lead early drug development

글 내용 전체보기

Janssen plunks down $100M for MeiraGTx’s retinal disease gene therapy pipeline

글 내용 전체보기

Treating melanoma by turning off a common mutation

글 내용 전체보기

Samsung BioLogics to double utilization of 3rd plant by end of year

글 내용 전체보기

Hitachi brings cell therapy biz to Europe through $86m apceth buy

글 내용 전체보기

Identity crisis of satiety neurons leads to obesity

글 내용 전체보기

Going for an MRI scan with tattoos?

글 내용 전체보기

First genetic switch for C. elegans developed

글 내용 전체보기

Beckman Coulter strenghtens laboratory automation business

글 내용 전체보기

Lonza Announces Succession of CEO

글 내용 전체보기